PEA for Allergic Rhinitis and Hay Fever: What the Randomized Trial Actually Found
A randomized placebo-controlled trial tested PEA for seasonal hay fever. It missed its primary endpoint. What the subgroup and blood markers showed instead.
PEA for Glaucoma and Eye Pressure: What the Clinical Trials Actually Show
What the glaucoma trials on PEA measured, including the 2011 crossover study and normal-tension data, and how much eye pressure actually changed.
PEA for Pets: Is Palmitoylethanolamide Safe and Effective for Dogs and Cats?
Veterinarians have used palmitoylethanolamide in dogs and cats for years. Here’s what a 2026 randomized trial and the older dermatology research actually show, and why giving your pet a human PEA capsule isn’t the same thing.
PEA for Dry Eye Disease: What Topical and Oral Palmitoylethanolamide Research Shows
PEA for dry eye disease: the pilot trial in glaucoma-related ocular surface disease, the preclinical data, and how eye drops differ from oral PEA.
PEA and Luteolin Together: Why This Combination Keeps Appearing in Research and Products
Why PEA and luteolin keep appearing together: what luteolin adds, the post-COVID olfactory and stroke rehabilitation data, and where it does not apply.
PEA for Chemotherapy-Induced Peripheral Neuropathy (CIPN): What Cancer Patients Should Know
PEA for chemotherapy-induced neuropathy: a promising 2011 pilot, a 2024 phase II trial with a different result, and what cancer patients should know.
PEA vs. Pregabalin (Lyrica): A Plain-Language Comparison of Two Non-Opioid Nerve Pain Options
Compare palmitoylethanolamide (PEA) and pregabalin (Lyrica) for neuropathic pain — mechanisms, evidence, side effects, and practical considerations.
Palmitoylethanolamide vs CBD: Mechanisms, Evidence, and How to Choose
PEA and CBD both target inflammation and discomfort through distinct pathways. Learn the key differences, shared ground, and which may suit your situation.
PEA During Pregnancy and Breastfeeding: What the Evidence (and Gaps) Show
PEA safety in pregnancy and breastfeeding: what preclinical data, breast milk research, and critical evidence gaps actually show.
Palmitoylethanolamide for Neuropathic Pain: A Review of Human Randomized Controlled Trials
An evidence-based review of human RCTs on palmitoylethanolamide (PEA) for neuropathic pain — mechanism, clinical findings, formulations, and safety.
Palmitoylethanolamide (PEA) for Long COVID: Neuroinflammation, Brain Fog, and Post-Viral Pain
Explore the clinical evidence on palmitoylethanolamide (PEA) for long COVID symptoms including brain fog, olfactory loss, fatigue, and post-viral pain.
What ‘Endogenous’ Means for PEA—and Why It Matters for Pain and Inflammation
PEA is a fatty acid your body already makes. Understanding what ‘endogenous’ means reveals why PEA supplements work differently from most anti-inflammatories.